Press Release
METAMARK GENETICS INITIATES CLINICAL USE OF ProMark™
Metamark Genetics, Inc. today announced that it has initiated clinical use of the company’s ProMark™ prognostic test to help guide the medical management of patients with early-stage prostate cancer.
read article
Press Release
Metamark Announces Appointment of Dr. Peter Blume-Jensen to its Scientific Advisory Board
Metamark today announced that its Chief Scientific Officer, Peter Blume-Jensen, M.D., Ph.D., will be joining a targeted therapeutics startup, and will continue working for Metamark as a member of the company’s Scientific Advisory Board and as a consultant.
read article